Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)

Exclusion Criteria

• •Patients with severe cardiovascular and hepatic disorders
• •Patients with complications of central nervous vascular disorders
• •Women who are breast feeding and females of childbearing potential who are not using acceptable contraceptive methods
• •Patients currently engaging in other experimental protocol
• •Patients with intracranial aneurysma
• •Patients who must use diuretics
• •Allergic patients to Candesartan or Cilnidipine
• •Patients whose hypertension is not controlled by medication of this protocol